BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...

Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...

Regularly blowing through a conch shell for six months significantly improved sleep among a small group of people with sleep ...

On July 29, he was removed from his role after some conservative figures such as far-right activist and conspiracy theorist Laura Loomer criticized his approach to drug approvals and his past ...

In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...

A reusable product can help save money over the long term. Celikoyar estimates that she was using three tampons every day for ...

President Trump’s effort to lessen crime in Washington, D.C., and launch a “beautification” effort is clashing with a long tradition of Republicans criticizing and outright writing off the ...

Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...

This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...